Lung Cancer
Breakthrough advances from ASCO 2025
In this ASCO 2025 edition of VJOncology podcasts, we spotlight five game-changing studies set to reshape cancer care across multiple…
Date: 13th June 2025
VJOncoAlert Journal Club
In this week’s podcast, we take you through the latest episodes of the VJOncoAlert Journal Club—a collaborative series from VJOncology…
Date: 25th April 2025
BTOG 2025 Highlights
In this weeks VJOncology podcast, we explore key update from BTOG 2025 in thoracic oncology. Prof. Sanjay Popat discusses the…
Date: 21st March 2025
Novel immune checkpoint targets beyond PD-1 and CTLA-4 in solid tumors
This week’s podcast from VJOncology brings you the latest updates on novel checkpoint inhibitors that target LAG-3, TIGIT, and TIM3…
Date: 10th January 2025
Climate Change and Other Environmental Factors on Lung Cancer Risk at WCLC 2024
In this week’s podcast, we explore the critical links between environmental factors and lung cancer risk, focusing on the impacts…
Date: 8th November 2024
ELCC 2024 Highlights
This week, we bring you key highlights from European Lung Cancer Congress (ELCC) 2024, which took place in Prague, Czech…
Date: 24th May 2024
BTOG 2024 Highlights
Tune in to an insightful podcast hosted by VJOncology, featuring experts from BTOG 2024 discussing advancements in lung cancer research….
Date: 26th April 2024
Highlights from AACR 2024: KRYSTAL-1, FLAURA2, and EDGE
This week, we cover key updates from the American Association for Cancer Research (AACR) 2024 Annual Meeting, held in San…
Date: 12th April 2024
Targeted therapies for lung cancer at TTLC 2024
This week, we cover interesting research from TTLC 2024, focusing on innovative treatments for lung cancer. Starting off, Bruna Pellini…
Date: 1st March 2024
Key updates at ESMO Asia 2023
The recent European Society for Medical Oncology (ESMO) Asia 2023 Congress in Singapore, brought together key oncology experts to delve…
Date: 26th January 2024
Highlights in lung cancer from ESMO 2023
The European Society for Medical Oncology Annual Meeting (ESMO) 2023 brought together thousands of experts in oncology to hear new…
Date: 10th November 2023
EGFR exon 20 insertions and how to manage patients in the UK
EGFR exon 20 insertion mutations represent 5% to 10% of EGFR mutations in patients with non-small cell lung cancer (NSCLC)….
Date: 13th October 2023
